跳至主要内容
临床试验/ISRCTN95881792
ISRCTN95881792进行中(未招募)未知

SARS-CoV-2 Vaccination for COVID-19 Disease Safety Study (VAC4COVID Study): a prospective, active observational, post-authorisation surveillance safety study (PASS) of vaccines for COVID-19 disease

niversity of Dundee0 个研究点目标入组 21,104 人开始时间: 2020年12月21日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
21,104

研究概览

简要总结

2022 Interim results article in https://pubmed.ncbi.nlm.nih.gov/35649591/ Adverse events and overall health and well-being after COVID-19 vaccination results (added 08/06/2022)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Adults aged 18 years and over (participants with primary caring responsibilities for children under the age of 18 may submit information on the child’s behalf with age-appropriate agreement)
  • 2. Valid email address (per adult participant) and able to access and use the internet
  • 3. Subjects willing to nominate at least one, preferably two, emergency contact(s)

排除标准

  • 1. No access to internet enabled devices to enable participation
  • 2. Unable to consent due to incapacity
  • 3. Unwilling or unable to nominate at least one emergency contact

研究者

发起方
niversity of Dundee

相似试验